These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20146628)

  • 1. Benefit or toxicity from neurologically targeted antiretroviral therapy?
    Brew BJ
    Clin Infect Dis; 2010 Mar; 50(6):930-2. PubMed ID: 20146628
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
    Cysique LA; Maruff P; Brew BJ
    Neurology; 2006 May; 66(9):1447-50. PubMed ID: 16682686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive impairment and neuroCART.
    Wright E
    Curr Opin HIV AIDS; 2011 Jul; 6(4):303-8. PubMed ID: 21546833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
    Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
    J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
    [No Abstract]   [Full Text] [Related]  

  • 5. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging manifestations of HIV/AIDS: is it the virus or the antiviral therapy?
    Laurence J
    AIDS Read; 2001 Feb; 11(2):64-5. PubMed ID: 11279873
    [No Abstract]   [Full Text] [Related]  

  • 7. [HIV eradication--facts and fiction].
    Jaeger H; Wolf E
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of HIV infection from the neurologic viewpoint. Therapy must reach the brain].
    von Giesen HJ; Köller H; Arendt G
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():46-50. PubMed ID: 12043074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Which antiretroviral strategy to use in adults?].
    Tonnerre P
    Rev Infirm; 2003 Sep; (93):12-6. PubMed ID: 14593983
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
    Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
    HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV, the brain, children, HAART and 'neuro-HAART': a complex mix.
    Brew BJ
    AIDS; 2009 Sep; 23(14):1909-10. PubMed ID: 19550290
    [No Abstract]   [Full Text] [Related]  

  • 14. When and why to start antiretroviral therapy?
    Gatell JM
    J Antimicrob Chemother; 2010 Mar; 65(3):383-5. PubMed ID: 20071369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Szczech LA
    Curr Opin HIV AIDS; 2009 May; 4(3):167-70. PubMed ID: 19532045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurological manifestations of the HIV infection].
    Arendt G; Nolting T
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():75-7. PubMed ID: 16385884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and CD4+ T cell count recovery among antiretroviral therapy-naive patients with HIV/AIDS.
    Naggie S; Hseih T; Reckleff J; Castellano J; Hicks CB
    Clin Infect Dis; 2009 Nov; 49(10):1619-20. PubMed ID: 19857170
    [No Abstract]   [Full Text] [Related]  

  • 19. [HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
    Kishida S
    No To Shinkei; 2004 Apr; 56(4):301-10. PubMed ID: 15237721
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV viremia and the development of AIDS-related lymphoma in patients treated with highly active antiretroviral therapy.
    Sabin CA
    J Infect Dis; 2009 Jul; 200(1):8-10. PubMed ID: 19476436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.